RETRACTED ARTICLE: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

V. La, R. Fujikawa, D. M. Janzen, M. Nunez, L. Bainvoll, L. Hwang, K. Faull, G. Lawson, S. Memarzadeh

DOI: 10.1038/s41698-017-0008-z
Published: 2017-04-03
Container: npj Precision Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

serious concern Score 11/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-017-0008-z,
  title = {RETRACTED ARTICLE: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy},
  author = {V. La and R. Fujikawa and D. M. Janzen and M. Nunez and L. Bainvoll and L. Hwang and K. Faull and G. Lawson and S. Memarzadeh},
  year = {2017},
  journal = {npj Precision Oncology},
  doi = {10.1038/s41698-017-0008-z},
  url = {https://doi.org/10.1038/s41698-017-0008-z}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
AU  - V. La
AU  - R. Fujikawa
AU  - D. M. Janzen
AU  - M. Nunez
AU  - L. Bainvoll
AU  - L. Hwang
AU  - K. Faull
AU  - G. Lawson
AU  - S. Memarzadeh
PY  - 2017
JO  - npj Precision Oncology
DO  - 10.1038/s41698-017-0008-z
UR  - https://doi.org/10.1038/s41698-017-0008-z
ER  -

APA

La, V., Fujikawa, R., Janzen, D. M., Nunez, M., Bainvoll, L., Hwang, L., Faull, K., Lawson, G., & Memarzadeh, S. (2017). RETRACTED ARTICLE: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy. npj Precision Oncology. https://doi.org/10.1038/s41698-017-0008-z

Source records

crossref · retrieved 2026-09-26T11:51:33.540Z